Dass der Blutdruck auch bei Älteren und Hochbetagten eingestellt werden soll, steht außer Frage. Die Hypertonie unbehandelt zu lassen ist keine Option. Auf welche Werte die Einstellung erfolgen soll, ist allerdings einer Diskussion würdig und wird unterschiedlich gesehen. Lesen Sie eine ausführliche Erörterung des Themas durch zwei Experten.
Literatur
Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219
James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20
Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324
Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041
Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98
Group SR, Wright JT, Jr., Williamson JD et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–16
Williamson JD, Supiano MA, Applegate WB et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged.75 Years: A Randomized Clinical Trial. JAMA. 2016;315(24):2673–82
Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014(3):CD000029.
Messerli FH, Mancia G, Conti CR et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884–93
McEvoy JW, Chen Y, Rawlings A et al. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol. 2016;68(16):1713–22
Filipovsky J, Seidlerova J, Kratochvil Z et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25(4):228–34
Cheung AK, Rahman M, Reboussin DM et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28(9):2812–23
Hajjar I, Rosenberger KJ, Kulshreshtha A et al. Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity. JAMA Neurol. 2017;74(10):1199–205
Johnson KC, Whelton PK, Cushman WC et al. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018;71(5):848–57
Bauer F, Seibert FS, Rohn B, Bauer KAR, Rolshoven E, Babel N, et al. Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting. Hypertension. 2018;71(2):243–9
Bohm M, Schumacher H, Teo KK et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226–37
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Westhoff, T.H. Absenkung der Zielblutdruckwerte im Alter. CV 19, 27–29 (2019). https://doi.org/10.1007/s15027-019-1511-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15027-019-1511-7